Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 9, Issue 2, pp. 389-399
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 21, 2009
- Revision received November 11, 2009
- Accepted November 24, 2009
- Published first January 26, 2010.
Article Versions
- Previous version (January 26, 2010 - 08:20).
- You are viewing the most recent version of this article.
Copyright & Usage
©2010 American Association for Cancer Research.
Author Information
- Jae-Ho Lee1,
- Sun Choi2,
- Yoonji Lee2,
- Hyo-Jeong Lee1,3,
- Kwan-Hyun Kim1,
- Kyoo-Seok Ahn1,
- Hyunsoo Bae1,
- Hyo-Jung Lee1,
- Eun-Ok Lee1,
- Kwang-Seok Ahn1,
- Shi Yong Ryu4,
- Junxuan Lü3 and
- Sung-Hoon Kim1,3
- Authors' Affiliations: 1Cancer Preventive Material Development Research Center, College of Oriental Medicine, Kyunghee University and 2College of Pharmacy, National Core Research Center for Cell Signaling and Drug Discovery, Ewha Womans University, Seoul, Korea; 3The Hormel Institute, University of Minnesota, Austin, Minnesota; and 4Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon, Korea
- Corresponding Authors:
Sung-Hoon Kim, College of Oriental Medicine, Kyunghee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul 131-701, Republic of Korea. E-mail: sungkim7{at}khu.ac.kr or Junxuan Lü, Hormel Institute, University of Minnesota, 801 16th Avenue Northeast, Austin, MN 55912. Phone: 507-437-9680; Fax: 507-437-9606. E-mail: jlu{at}hi.umn.edu
February 2010
Volume 9, Issue 2
Volume 9, Issue 2
Herbal Compound Farnesiferol C Exerts Antiangiogenic and Antitumor Activity and Targets Multiple Aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) Signaling Cascades
Jump to section
Advertisement